Evidence map›Paper›PMID 35205701›Full record

ArticleCancers2022

Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line Therapy.

Anouk Steur, Paulien A M A Raymakers-Janssen, Martin C J Kneyber, Sandra Dijkstra, Job B M van Woensel, Dick A van Waardenburg, Cornelis P van de Ven, Alida F W van der Steeg, Marc Wijnen, Marc R Lilien and 10 more

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Anouk SteurPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0001-5531-6027
Paulien A M A Raymakers-JanssenPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Martin C J KneyberDivision of Pediatric Critical Care Medicine, Beatrix Children's Hospital/University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Sandra DijkstraDivision of Pediatric Critical Care Medicine, Beatrix Children's Hospital/University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Job B M van WoenselDepartment of Pediatric Intensive Care, Amsterdam University Medical Centers, 1105 AZ Amsterdam, The Netherlands.
Dick A van WaardenburgDepartment of Pediatric Intensive Care, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
Cornelis P van de VenPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Alida F W van der SteegPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0003-0168-7513
Marc WijnenPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Marc R LilienDepartment of Pediatric Nephrology, Wilhelmina Children's Hospital/University Medical Center Utrecht, 3584 EA Utrecht, The Netherlands.
Ronald R de KrijgerPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Harm van TinterenPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0002-4626-8702
Annemieke S LittooijDepartment of Radiology, Wilhelmina Children's Hospital/University Medical Center Utrecht, 3584 EA Utrecht, The Netherlands.
Geert O JanssensPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Annemarie M L PeekPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Godelieve A M TytgatPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Annelies M Mavinkurve-GroothuisPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0002-6984-3626
Martine van GrotelPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Marry M van den Heuvel-EibrinkPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Roelie M Wösten-van AsperenDepartment of Pediatric Intensive Care, Wilhelmina Children's Hospital/University Medical Center Utrecht, 3584 EA Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Survival rates are excellent for children with Wilms tumor (WT), yet tumor and treatment-related complications may require pediatric intensive care unit (PICU) admission. We assessed the frequency, clinical characteristics, and outcome of children with WT requiring PICU admissions in a multicenter, retrospective study in the Netherlands. Admission reasons of unplanned PICU admissions were described in relation to treatment phase. Unplanned PICU admissions were compared to a control group of no or planned PICU admissions, with regard to patient characteristics and short and long term outcomes. In a multicenter cohort of 175 children with an underlying WT, 50 unplanned PICU admissions were registered in 33 patients. Reasons for admission were diverse and varied per treatment phase. Younger age at diagnosis, intensive chemotherapy regimens, and bilateral tumor surgery were observed in children with unplanned PICU admission versus the other WT patients. Three children required renal replacement therapy, two of which continued dialysis after PICU discharge (both with bilateral disease). Two children died during their PICU stay. During follow-up, hypertension and chronic kidney disease (18.2 vs. 4.2% and 15.2 vs. 0.7%) were more frequently observed in unplanned PICU admitted patients compared to the other patients. No significant differences in cardiac morbidity, relapse, or progression were observed. Almost 20% of children with WT required unplanned PICU admission, with young age and treatment intensity as potential risk factors. Hypertension and renal impairment were frequently observed in these patients, warranting special attention at presentation and during treatment and follow-up.

Indexed as

intensive careoutcomepediatric oncologyrisk factorsWilms tumor

Identifiers

PMID35205701
PMCPMC8870004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.